{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:03:22Z","timestamp":1794265402937,"version":"4.9.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.critrevonc.2026.105167","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T16:27:33Z","timestamp":1769790453000},"page":"105167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Adjuvant aspirin and Cyclooxygenase-2 inhibitors in resected, PIK3CA-mutated colorectal cancer: A systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"220","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3252-7144","authenticated-orcid":false,"given":"Ellen R.","family":"Blanchard-Cavagis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro C.","family":"Abrah\u00e3o Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipe Luis Vasconcelos","family":"Visani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helo\u00edsa","family":"Carneiro Brito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela C.","family":"Diniz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caio","family":"Dabbous de Liz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.critrevonc.2026.105167_bib1","first-page":"e596","article-title":"2019 ACC\/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105167_bib2","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMoa021735","article-title":"A Randomized Trial of Aspirin to Prevent Colorectal Adenomas","volume":"348","author":"Baron","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105167_bib3","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.annonc.2020.02.012","article-title":"Aspirin and the Risk of Colorectal and Other Digestive Tract Cancers: An Updated Meta-Analysis through 2019","volume":"31","author":"Bosetti","year":"2020","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105167_bib4","first-page":"229","article-title":"Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"janvier","key":"10.1016\/j.critrevonc.2026.105167_bib5","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jclinepi.2020.09.018","article-title":"GRADE Guidelines 30: The GRADE Approach to Assessing the Certainty of Modeled Evidence-An Overview in the Context of Health Decision-Making","volume":"129","author":"Brozek","year":"2021","journal-title":"J. Clin. Epidemiol."},{"issue":"5753","key":"10.1016\/j.critrevonc.2026.105167_bib6","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1126\/science.1116221","article-title":"Prostaglandin E2 Promotes Colon Cancer Cell Growth through a Gs-Axin-Beta-Catenin Signaling Axis","volume":"310","author":"Castellone","year":"2005","journal-title":"Science (New York N. Y. )"},{"key":"10.1016\/j.critrevonc.2026.105167_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fonc.2014.00035","article-title":"PIK3CA in Colorectal Cancer","volume":"4","author":"Cathomas","year":"2014","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105167_bib8","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jama.294.8.914","article-title":"Long-Term Use of Aspirin and Nonsteroidal Anti-Inflammatory Drugs and Risk of Colorectal Cancer","volume":"294","author":"Chan","year":"2005","journal-title":"JAMA"},{"issue":"21","key":"10.1016\/j.critrevonc.2026.105167_bib9","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1056\/NEJMoa067208","article-title":"Aspirin and the Risk of Colorectal Cancer in Relation to the Expression of COX-2","volume":"356","author":"Chan","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105167_bib10","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/jama.2009.1112","article-title":"Aspirin Use and Survival after Diagnosis of Colorectal Cancer","volume":"302","author":"Chan","year":"2009","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105167_bib11","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S2468-1253(24)00387-X","article-title":"Aspirin after Completion of Standard Adjuvant Therapy for Colorectal Cancer (ASCOLT): An International, Multicentre, Phase 3, Randomised, Double-Blind, Placebo-Controlled Trial","volume":"10","author":"Chia","year":"2025","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.critrevonc.2026.105167_bib12","unstructured":"Cochrane Methods 2023 - Cochrane Methods. Random-Effects Meta-Analysis Methods for Intervention Reviews. Available from \u3008https:\/\/methods.cochrane.org\/methods\u3009- cochrane\/random-effects-meta-analysis-methods-intervention- reviews. Accessed August 20, 2025."},{"issue":"34","key":"10.1016\/j.critrevonc.2026.105167_bib13","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1200\/JCO.2013.50.0322","article-title":"Evaluation of PIK3CA Mutation as a Predictor of Benefit from Nonsteroidal Anti-Inflammatory Drug Therapy in Colorectal Cancer","volume":"31","author":"Domingo","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"d\u00e9cembre","key":"10.1016\/j.critrevonc.2026.105167_bib14","doi-asserted-by":"crossref","first-page":"i6188","DOI":"10.1136\/bmj.i6188","article-title":"Chemoprevention of Colorectal Cancer in Individuals with Previous Colorectal Neoplasia: Systematic Review and Network Meta-Analysis","volume":"355","author":"Dulai","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.critrevonc.2026.105167_bib15","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/504230","article-title":"The Proapoptotic Effect of Traditional and Novel Nonsteroidal Anti-Inflammatory Drugs in Mammalian and Yeast Cells","volume":"2013","author":"Farrugia","year":"2013","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105167_bib16","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, Inflammation, and Cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"issue":"15","key":"10.1016\/j.critrevonc.2026.105167_bib17","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1158\/1078-0432.CCR-24-4048","article-title":"Adjuvant Aspirin Treatment in PIK3CA-Mutated Colon Cancer Patients: The SAKK 41\/13 Prospective Randomized Placebo-Controlled Double-Blind Trial","volume":"31","author":"G\u00fcller","year":"2025","journal-title":"Clin. Cancer Res."},{"issue":"24","key":"10.1016\/j.critrevonc.2026.105167_bib18","doi-asserted-by":"crossref","first-page":"10280","DOI":"10.1158\/0008-5472.CAN-08-1957","article-title":"Methylation of Polycomb Target Genes in Intestinal Cancer Is Mediated by Inflammation","volume":"68","author":"Hahn","year":"2008","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105167_bib19","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00018-022-04430-y","article-title":"Aspirin Sensitivity of PIK3CA-Mutated Colorectal Cancer: Potential Mechanisms Revisited","volume":"79","author":"Hall","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105167_bib20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.molmed.2009.04.002","article-title":"Epithelial Metaplasia: Adult Stem Cell Reprogramming and (Pre)Neoplastic Transformation Mediated by Inflammation?","volume":"15","author":"Herfs","year":"2009","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.critrevonc.2026.105167_bib21","unstructured":"J.P.T. Higgins, J. Thomas, J. Chandler, M. Cumpston, T. Li, M.J. Page, V.A. Welch (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated August 2024). Cochrane, 2024. \u3008www.cochrane.org\/handbook\u3009. (accessed 20 August 2025)."},{"issue":"35","key":"10.1016\/j.critrevonc.2026.105167_bib22","article-title":"Overall Survival of Colorectal Cancer by Stage at Diagnosis: Data from the Martinique Cancer Registry","volume":"98","author":"Joachim","year":"2019","journal-title":"Med. (Baltim. )"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105167_bib23","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1056\/NEJMoa071841","article-title":"Rofecoxib and Cardiovascular Adverse Events in Adjuvant Treatment of Colorectal Cancer","volume":"357","author":"Kerr","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105167_bib24","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.cgh.2011.05.020","article-title":"Low Doses of Acetylsalicylic Acid Increase Risk of Gastrointestinal Bleeding in a Meta-Analysis","volume":"9","author":"Lanas","year":"2011","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"17","key":"10.1016\/j.critrevonc.2026.105167_bib25","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1056\/NEJMoa1207756","article-title":"Aspirin Use, Tumor PIK3CA Mutation, and Colorectal-Cancer Survival","volume":"367","author":"Liao","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105167_bib26","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00432-022-03942-1","article-title":"Meta-Analysis of Aspirin-Guided Therapy of Colorectal Cancer","volume":"148","author":"M\u00e4dge","year":"2022","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105167_bib27","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1056\/NEJMoa2504650","article-title":"Low-Dose Aspirin for PI3K-Altered Localized Colorectal Cancer","volume":"393","author":"Martling","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"13","key":"10.1016\/j.critrevonc.2026.105167_bib28","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1001\/jama.2021.2454","article-title":"Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB\/SWOG 80702 (Alliance) Randomized Clinical Trial","volume":"325","author":"Meyerhardt","year":"2021","journal-title":"JAMA"},{"issue":"30","key":"10.1016\/j.critrevonc.2026.105167_bib29","doi-asserted-by":"crossref","first-page":"4575","DOI":"10.1200\/JCO.2010.29.6244","article-title":"Phase III Randomized Trial Assessing Rofecoxib in the Adjuvant Setting of Colorectal Cancer: Final Results of the VICTOR Trial","volume":"28","author":"Midgley","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105167_bib30","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/s41698-025-00975-w","article-title":"Comprehensive Analysis of PIK3CA Mutations in Advanced Colorectal Cancer Using Circulating Tumor DNA Profiling","volume":"9","author":"Milsap","year":"2025","journal-title":"NPJ Precis. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105167_bib31","unstructured":"National Comprehensive Cancer Network 2025 - National Comprehensive Cancer Network. NCCN Guidelines Version 4.2025 dMMR\/MSI-H Colon Cancer. \u3008https:\/\/www.nccn.org\/guidelines\/guidelines-detail?id=1428\u3009. (accessed 20 August 2025)."},{"key":"10.1016\/j.critrevonc.2026.105167_bib32","unstructured":"National Institutes of Health 2017 - National Institutes of Health, National Cancer Institute, et U.S.DEPARTMENT OF HEALTH AND HUMAN SERVICES. Common Terminology Criteria for Adverse Events (CTCAE). \u3008https:\/\/dctd.cancer.gov\/research\/ctep-trials\/for-sites\/adverse-events\/ctcae-v5-5\u00d77.pdf\u3009. (accessed 10 September 2025)."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105167_bib33","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1001\/jamaoncol.2023.5098","article-title":"Incidence of Recurrence and Time to Recurrence in Stage I to III Colorectal Cancer: A Nationwide Danish Cohort Study","volume":"10","author":"Nors","year":"2024","journal-title":"JAMA Oncol."},{"issue":"24","key":"10.1016\/j.critrevonc.2026.105167_bib34","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1200\/JCO.23.01680","article-title":"Improved Survival With Adjuvant Cyclooxygenase 2 Inhibition in PIK3CA-Activated Stage III Colon Cancer: CALGB\/SWOG 80702 (Alliance)","volume":"42","author":"Nowak","year":"2024","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105167_bib35","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1200\/JCO.2008.18.6544","article-title":"PIK3CA Mutation Is Associated with Poor Prognosis among Patients with Curatively Resected Colon Cancer","volume":"27","author":"Ogino","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"mars","key":"10.1016\/j.critrevonc.2026.105167_bib36","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105167_bib37","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.clon.2015.11.008","article-title":"PIK3CA Mutation, Aspirin Use after Diagnosis and Survival of Colorectal Cancer. A Systematic Review and Meta-Analysis of Epidemiological Studies","volume":"28","author":"Paleari","year":"2016","journal-title":"Clin. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105167_bib38","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1124\/jpet.122.001631","article-title":"Cyclooxygenase Inhibitors and Cancer: The Missing Pieces","volume":"386","author":"Patrono","year":"2023","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"22","key":"10.1016\/j.critrevonc.2026.105167_bib39","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1056\/NEJMra052717","article-title":"Low-Dose Aspirin for the Prevention of Atherothrombosis","volume":"353","author":"Patrono","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"janvier","key":"10.1016\/j.critrevonc.2026.105167_bib40","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1146\/annurev-pathol-042320-034052","article-title":"Precision Medicine in Low- and Middle-Income Countries","volume":"17","author":"Radich","year":"2022","journal-title":"Annu. Rev. Pathol."},{"issue":"janvier","key":"10.1016\/j.critrevonc.2026.105167_bib41","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1146\/annurev-med-051019-102940","article-title":"Aspirin in the Prevention of Cardiovascular Disease and Cancer","volume":"72","author":"Ricciotti","year":"2021","journal-title":"Annu. Rev. Med."},{"issue":"5670","key":"10.1016\/j.critrevonc.2026.105167_bib42","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1126\/science.1096502","article-title":"High Frequency of Mutations of the PIK3CA Gene in Human Cancers","volume":"304","author":"Samuels","year":"2004","journal-title":"Science"},{"issue":"23","key":"10.1016\/j.critrevonc.2026.105167_bib43","doi-asserted-by":"crossref","first-page":"9018","DOI":"10.3390\/ijms21239018","article-title":"Mechanisms of Colorectal Cancer Prevention by Aspirin-A Literature Review and Perspective on the Role of COX-Dependent and -Independent Pathways","volume":"21","author":"Sankaranarayanan","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105167_bib44","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1158\/0008-5472.CAN-08-2466","article-title":"PIK3CA Mutations in Colorectal Cancer Are Associated with Clinical Resistance to EGFR-Targeted Monoclonal Antibodies","volume":"69","author":"Sartore-Bianchi","year":"2009","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105167_bib45","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/cam4.4859","article-title":"Low-Dose Aspirin Use and Colorectal Cancer Survival in 32,195 Patients-A National Cohort Study","volume":"12","author":"Shahrivar","year":"2023","journal-title":"Cancer Med."},{"issue":"ao\u00fbt","key":"10.1016\/j.critrevonc.2026.105167_bib46","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: A Revised Tool for Assessing Risk of Bias in Randomised Trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105167_bib47","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41419-018-0776-6","article-title":"PIK3CA Mutations Confer Resistance to First-Line Chemotherapy in Colorectal Cancer","volume":"9","author":"Wang","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.critrevonc.2026.105167_bib48","article-title":"The Role of PIK3CA Gene Mutations in Colorectal Cancer and the Selection of Treatment Strategies","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Pharm."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826000545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826000545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T19:53:36Z","timestamp":1776974016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826000545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":48,"alternative-id":["S1040842826000545"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105167","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjuvant aspirin and Cyclooxygenase-2 inhibitors in resected, PIK3CA-mutated colorectal cancer: A systematic review and meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105167","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105167"}}